Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WillowWood is a long-established prosthetics company focused on the design, manufacture, and distribution of prosthetic products for people with limb loss. Founded in Ohio in 1907, the company markets a commercial portfolio that includes prosthetic liners, feet, vacuum systems, components, custom socket solutions, and CAD-based prosthetic design tools. The business has historically been known as Ohio Willow Wood and now operates as WillowWood Global, backed by private equity owner Blue Sea Capital. In recent years, WillowWood has expanded beyond its core liner franchise into powered prostheses, myoelectrics, thermoformable socket materials, and acquired technologies such as MAKstride and Xtremity. The company serves prosthetic clinicians and patients globally through direct operations and an international distributor network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WillowWood.